ArticleOncotarget2015

Inhibition of RSK with the novel small-molecule inhibitor LJI308 overcomes chemoresistance by eliminating cancer stem cells.

Alastair H Davies et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.